1. Congenital Malformations Surveillance: Two American Systems
2. Food and Drug Administration, Center for Drug and Evaluation Research. Dermatologic Drugs Advisory Committee open public hearing on Accutane (isotretinoin) capsules. April 26, 1988. NDA-18-662.
3. Food and Drug Administration. Center for Drug and Evaluation Research. Dermatologic Drugs Advisory Committee open public hearing on Accutane (isotretinoin) capsules. May 8, 1989. F89-285-65.
4. (1988) Smith's Recognizable Patterns of Human Malformation, 4th ed. W.B. Saunders Company, Philadelphia.
5. Monitoring for multiple malformations in the detection of epidemics of birth defects